These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 37238943)

  • 21. The role of gut dysbiosis in Parkinson's disease: mechanistic insights and therapeutic options.
    Wang Q; Luo Y; Ray Chaudhuri K; Reynolds R; Tan EK; Pettersson S
    Brain; 2021 Oct; 144(9):2571-2593. PubMed ID: 33856024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Liver diseases: The pathogenetic role of the gut microbiome and the potential of treatment for its modulation].
    Aitbaev KA; Murkamilov IT; Fomin VV
    Ter Arkh; 2017; 89(8):120-128. PubMed ID: 28914862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Manual acupuncture benignly regulates blood-brain barrier disruption and reduces lipopolysaccharide loading and systemic inflammation, possibly by adjusting the gut microbiota.
    Zhang Y; Ding N; Hao X; Zhao J; Zhao Y; Li Y; Li Z
    Front Aging Neurosci; 2022; 14():1018371. PubMed ID: 36313024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gut : liver : brain axis: the microbial challenge in the hepatic encephalopathy.
    Mancini A; Campagna F; Amodio P; Tuohy KM
    Food Funct; 2018 Mar; 9(3):1373-1388. PubMed ID: 29485654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gut microbiota-modulating agents in alcoholic liver disease: Links between host metabolism and gut microbiota.
    Jung JH; Kim SE; Suk KT; Kim DJ
    Front Med (Lausanne); 2022; 9():913842. PubMed ID: 35935787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gut Microbiota Interact With the Brain Through Systemic Chronic Inflammation: Implications on Neuroinflammation, Neurodegeneration, and Aging.
    Mou Y; Du Y; Zhou L; Yue J; Hu X; Liu Y; Chen S; Lin X; Zhang G; Xiao H; Dong B
    Front Immunol; 2022; 13():796288. PubMed ID: 35464431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Role of Intestinal Bacteria and Gut-Brain Axis in Hepatic Encephalopathy.
    Chen Z; Ruan J; Li D; Wang M; Han Z; Qiu W; Wu G
    Front Cell Infect Microbiol; 2020; 10():595759. PubMed ID: 33553004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microbiota-Immune System Interactions in Human Neurological Disorders.
    Huang Q; Yu F; Liao D; Xia J
    CNS Neurol Disord Drug Targets; 2020; 19(7):509-526. PubMed ID: 32713337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gut microbiota dysbiosis and Huntington's disease: Exploring the gut-brain axis and novel microbiota-based interventions.
    Sharma G; Biswas SS; Mishra J; Navik U; Kandimalla R; Reddy PH; Bhatti GK; Bhatti JS
    Life Sci; 2023 Sep; 328():121882. PubMed ID: 37356750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease.
    Sun MF; Shen YQ
    Ageing Res Rev; 2018 Aug; 45():53-61. PubMed ID: 29705121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Human Gut Microbiome as a Potential Factor in Autism Spectrum Disorder.
    Alharthi A; Alhazmi S; Alburae N; Bahieldin A
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gut microbiota and host metabolism in liver cirrhosis.
    Usami M; Miyoshi M; Yamashita H
    World J Gastroenterol; 2015 Nov; 21(41):11597-608. PubMed ID: 26556989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A narrative review of relationship between gut microbiota and neuropsychiatric disorders: mechanisms and clinical application of probiotics and prebiotics.
    Yang H; Liu Y; Cai R; Li Y; Gu B
    Ann Palliat Med; 2021 Feb; 10(2):2304-2313. PubMed ID: 33549028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microbiota-gut-liver-brain axis and hepatic encephalopathy.
    Lu H; Zhang H; Wu Z; Li L
    Microbiome Res Rep; 2024; 3(2):17. PubMed ID: 38841407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unraveling mechanistic insights into the role of microbiome in neurogenic hypertension: A comprehensive review.
    Dai Y; Shen Z; Khachatryan LG; Vadiyan DE; Karampoor S; Mirzaei R
    Pathol Res Pract; 2023 Sep; 249():154740. PubMed ID: 37567034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Zonulin-transgenic mouse displays behavioral alterations ameliorated via depletion of the gut microbiota.
    Miranda-Ribera A; Serena G; Liu J; Fasano A; Kingsbury MA; Fiorentino MR
    Tissue Barriers; 2022 Jul; 10(3):2000299. PubMed ID: 34775911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inflammatory Bowel Diseases: The Role of Gut Microbiota.
    De Musis C; Granata L; Dallio M; Miranda A; Gravina AG; Romano M
    Curr Pharm Des; 2020; 26(25):2951-2961. PubMed ID: 32310042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gut dysbiosis, defective autophagy and altered immune responses in neurodegenerative diseases: Tales of a vicious cycle.
    Chidambaram SB; Essa MM; Rathipriya AG; Bishir M; Ray B; Mahalakshmi AM; Tousif AH; Sakharkar MK; Kashyap RS; Friedland RP; Monaghan TM
    Pharmacol Ther; 2022 Mar; 231():107988. PubMed ID: 34536490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease.
    Suk KT; Kim DJ
    Expert Rev Gastroenterol Hepatol; 2019 Mar; 13(3):193-204. PubMed ID: 30791767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis.
    Zhao Z; Ning J; Bao XQ; Shang M; Ma J; Li G; Zhang D
    Microbiome; 2021 Nov; 9(1):226. PubMed ID: 34784980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.